Econopred

Inflammation, Conjunctivitis, Conjunctivitis + 4 more
Treatment
4 FDA approvals
20 Active Studies for Econopred

What is Econopred

Prednisolone acetateThe Generic name of this drug
Treatment SummaryPrednisolone acetate is a medication made up of prednisolone, which is connected to an acetate molecule. It was approved by the FDA in 1955 and is used to treat a variety of medical conditions.
Blephamideis the brand name
Econopred Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Blephamide
Prednisolone acetate
1961
39

Approved as Treatment by the FDA

Prednisolone acetate, also known as Blephamide, is approved by the FDA for 4 uses including Inflammation and Organ Transplantation .
Inflammation
Organ Transplantation
Inflammation
Inflammatory Conditions
Helps manage Inflammatory Conditions

Effectiveness

How Econopred Affects PatientsCorticosteroids help reduce inflammation by blocking pro-inflammatory signals and sending out anti-inflammatory signals. Prednisolone acetate works fast, but wears off quickly with a half life of 2-3 hours. It is safe to take in larger doses than what the body produces naturally. However, patients should be aware that this drug can suppress the body’s natural hormone system and make them more susceptible to infections.
How Econopred works in the bodyCorticosteroids reduce inflammation in the body by stopping white blood cells from moving to sites of inflammation and by blocking certain enzymes from forming. When taken in lower doses, corticosteroids can help reduce inflammation, but when taken in higher doses for a longer period of time, they can suppress the immune system. High doses of corticosteroids also increase sodium levels and decrease potassium levels.

When to interrupt dosage

The prescribed dose of Econopred is subject to the determined condition, including Ocular Infections, Irritations and Inflammations, Ocular Inflammation and Inflammatory Conditions. The dosage depends on the technique of delivery (e.g. Ophthalmic or Solution / drops - Ophthalmic) listed in the table underneath.
Condition
Dosage
Administration
Conjunctivitis
0.002 mg/mg, , 10.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.2 mg/mL, 0.2 %, 1.0 %, 0.12 %, 0.006 mg/mg, 0.5 %, 1.25 mg/mL, 1.0 mg/mL, 10.0 mg/mg, 1.25 mg, 5.0 mg/mL, 16.7 mg/mL, 0.005 mg/mg
, Ointment, Ophthalmic, Ointment - Ophthalmic, Suspension, Suspension - Oral, Suspension / drops, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Solution, Ophthalmic; Topical, Ointment - Ophthalmic; Topical, Oral, Kit - Ophthalmic, Kit
Conjunctivitis
0.002 mg/mg, , 10.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.2 mg/mL, 0.2 %, 1.0 %, 0.12 %, 0.006 mg/mg, 0.5 %, 1.25 mg/mL, 1.0 mg/mL, 10.0 mg/mg, 1.25 mg, 5.0 mg/mL, 16.7 mg/mL, 0.005 mg/mg
, Ointment, Ophthalmic, Ointment - Ophthalmic, Suspension, Suspension - Oral, Suspension / drops, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Solution, Ophthalmic; Topical, Ointment - Ophthalmic; Topical, Oral, Kit - Ophthalmic, Kit
Ocular Infections, Irritations and Inflammations
0.002 mg/mg, , 10.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.2 mg/mL, 0.2 %, 1.0 %, 0.12 %, 0.006 mg/mg, 0.5 %, 1.25 mg/mL, 1.0 mg/mL, 10.0 mg/mg, 1.25 mg, 5.0 mg/mL, 16.7 mg/mL, 0.005 mg/mg
, Ointment, Ophthalmic, Ointment - Ophthalmic, Suspension, Suspension - Oral, Suspension / drops, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Solution, Ophthalmic; Topical, Ointment - Ophthalmic; Topical, Oral, Kit - Ophthalmic, Kit
Organ Transplantation
0.002 mg/mg, , 10.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.2 mg/mL, 0.2 %, 1.0 %, 0.12 %, 0.006 mg/mg, 0.5 %, 1.25 mg/mL, 1.0 mg/mL, 10.0 mg/mg, 1.25 mg, 5.0 mg/mL, 16.7 mg/mL, 0.005 mg/mg
, Ointment, Ophthalmic, Ointment - Ophthalmic, Suspension, Suspension - Oral, Suspension / drops, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Solution, Ophthalmic; Topical, Ointment - Ophthalmic; Topical, Oral, Kit - Ophthalmic, Kit
Eye Infections, Bacterial
0.002 mg/mg, , 10.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.2 mg/mL, 0.2 %, 1.0 %, 0.12 %, 0.006 mg/mg, 0.5 %, 1.25 mg/mL, 1.0 mg/mL, 10.0 mg/mg, 1.25 mg, 5.0 mg/mL, 16.7 mg/mL, 0.005 mg/mg
, Ointment, Ophthalmic, Ointment - Ophthalmic, Suspension, Suspension - Oral, Suspension / drops, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Solution, Ophthalmic; Topical, Ointment - Ophthalmic; Topical, Oral, Kit - Ophthalmic, Kit
Inflammation
0.002 mg/mg, , 10.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.2 mg/mL, 0.2 %, 1.0 %, 0.12 %, 0.006 mg/mg, 0.5 %, 1.25 mg/mL, 1.0 mg/mL, 10.0 mg/mg, 1.25 mg, 5.0 mg/mL, 16.7 mg/mL, 0.005 mg/mg
, Ointment, Ophthalmic, Ointment - Ophthalmic, Suspension, Suspension - Oral, Suspension / drops, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Solution, Ophthalmic; Topical, Ointment - Ophthalmic; Topical, Oral, Kit - Ophthalmic, Kit
Inflammatory Conditions
0.002 mg/mg, , 10.0 mg, 10.0 mg/mL, 2.0 mg/mL, 1.2 mg/mL, 0.2 %, 1.0 %, 0.12 %, 0.006 mg/mg, 0.5 %, 1.25 mg/mL, 1.0 mg/mL, 10.0 mg/mg, 1.25 mg, 5.0 mg/mL, 16.7 mg/mL, 0.005 mg/mg
, Ointment, Ophthalmic, Ointment - Ophthalmic, Suspension, Suspension - Oral, Suspension / drops, Suspension / drops - Ophthalmic, Suspension - Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Solution - Ophthalmic, Solution, Ophthalmic; Topical, Ointment - Ophthalmic; Topical, Oral, Kit - Ophthalmic, Kit

Warnings

Econopred has a single contraindication, so it should not be utilized in cases of the conditions listed in the following table.Econopred Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Prednisolone Acetate may interact with Pulse Frequency
There are 20 known major drug interactions with Econopred.
Common Econopred Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Prednisolone acetate.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Prednisolone acetate.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Prednisolone acetate.
Alpelisib
Major
The metabolism of Alpelisib can be increased when combined with Prednisolone acetate.
Aminophylline
Major
The metabolism of Aminophylline can be increased when combined with Prednisolone acetate.
Econopred Toxicity & Overdose RiskThe lowest toxic dose of prednisolone acetate for mice is 1680 mg/kg. Someone who has overdosed on oral prednisolone acetate may experience an increase in the negative effects associated with corticosteroids. To treat an overdose, a doctor may suggest inducing vomiting, reducing the dose, or alternate-day therapy. An overdose through the ophthalmic route is not expected to lead to any problems.
image of a doctor in a lab doing drug, clinical research

Econopred Novel Uses: Which Conditions Have a Clinical Trial Featuring Econopred?

189 active trials are being conducted to analyze the potential of Econopred to reduce Inflammation, Inflammatory Conditions and superficial ocular infections.
Condition
Clinical Trials
Trial Phases
Inflammation
57 Actively Recruiting
Not Applicable, Early Phase 1, Phase 1, Phase 2, Phase 3, Phase 4
Conjunctivitis
0 Actively Recruiting
Eye Infections, Bacterial
0 Actively Recruiting
Ocular Infections, Irritations and Inflammations
0 Actively Recruiting
Conjunctivitis
0 Actively Recruiting
Organ Transplantation
0 Actively Recruiting
Inflammatory Conditions
1 Actively Recruiting
Phase 2

Econopred Reviews: What are patients saying about Econopred?

5Patient Review
2/8/2014
Econopred for Inflammation of the Eye Following Surgery
This was a good treatment for me.
4Patient Review
11/29/2007
Econopred for Inflammation of the Eye Following Surgery
This is working great so far, but does leave a weird taste in my mouth.
3.7Patient Review
11/20/2007
Econopred for Inflammation of the Iris - the Colored Part of the Eyeball
The medication is helping with my iritis, but it does have a weird aftertaste that comes from dripping down into my sinuses. The hardest part by far has been remembering to put the drops in every hour, but I'm still generally happy with the results.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about econopred

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Econopred Plus used for?

"This medication is used to treat certain eye conditions that are caused by inflammation or injury. Prednisolone works to relieve symptoms such as swelling, redness, and itching. It is classified as a corticosteroid drug."

Answered by AI

What does prednisolone treat?

"Prednisolone is a medication used to treat a variety of health conditions, such as allergies, blood disorders, skin diseases, inflammation, infections, and certain cancers. Additionally, it can also be used to prevent organ rejection after a transplant. Prednisolone does this by reducing swelling (inflammation) and calming down the immune system."

Answered by AI

What is the difference between Pred Forte and prednisolone?

"Prednisolone, also known as Pred Forte, is a corticosteroid medication used in the eye. These corticosteroids are man-made and mimic the effects of cortisol, a natural hormone produced by the body. Prednisolone works by reducing the levels of certain chemicals in the body that are responsible for causing itching, redness, swelling, or pain."

Answered by AI

How to use exopred?

"Exopred Eye Drop is used to treat bacterial infection of the eyes. It stops the growth of bacteria causing infection and helps relieve pain, swelling, redness, itching or irritation in the eyes."

Answered by AI

Clinical Trials for Econopred

Image of UConn Health in Farmington, United States.

Cognitive Remediation for Memory and Thinking Difficulties

18+
All Sexes
Farmington, CT
The goal of this clinical trial is to determine if a neuroscience-based computerized cognitive remediation ("brain training") program can treat neurocognitive dysfunction (i.e., memory or thinking difficulties) that emerges in some older adults following a viral infection. The main questions it aims to answer are: * Does computerized cognitive remediation improve cognitive performance and day-to-day functioning in older adults with postviral neurocognitive dysfunction? * Will treatment effects be maintained over time, leading to better long term cognitive outcomes? * Does the treatment lead to reductions in blood-based markers of inflammation as a potential mechanism of cognitive symptom improvement? * Can the treatment be optimized and refined based on feedback from participants to improve user (patient) experience? Researchers will compare the computerized cognitive remediation program to an active computer-based control condition (alternative computer activities) to see if the computerized cognitive remediation program works to treat postviral neurocognitive dysfunction. Participation takes approximately 43-48 hours over 7 months, with most activities (40-46 hours) completed within the first 7-8 weeks, including: * Initial intake visit: Eligibility confirmation (\~2-3 hours) * Computer activities: About 5 hours per week for \~6 weeks (total \~30 hours) completed on a computer tablet provided by the study and loaned to participants for use during the treatment phase * Weekly remote check-in meetings: \~30 minutes each during treatment * Blood draws: Two sessions (before and after treatment), \~20-30 minutes each * Three research visits: Pre-treatment, post-treatment, and 6-month follow-up (\~2-3 hours each, including assessments of cognitive, emotional, and daily functioning)
Waitlist Available
Has No Placebo
UConn HealthCutter Lindbergh, Ph.D.
Image of Department of Nutritional Sciences in Storrs, United States.

Freeze-dried Grape Powder for Healthy Aging

50 - 75
All Sexes
Storrs, CT
The purpose of this study is to investigate the effects of consuming grape powder on immune profiles in healthy middle- and older-aged individuals. Specifically, the investigators are interested in evaluating the potential effects of grapes in influencing markers of immune function, inflammation, and metabolism that are known to change with aging. Grapes contain several nutrients and antioxidant polyphenols such as resveratrol, quercetin, vitamin K and fiber, which are known to promote heart and immune health. However, the effects of grapes on altering immune profiles within the context of aging is not well understood. Therefore, this study will explore how daily grape consumption impacts certain markers of immunity in healthy middle- and older-aged adults. The main study procedures include consumption of a freeze-dried grape powder and control powder (which tastes the same but has none of the grape compounds that are being studied) mixed with water as a beverage on a daily basis for 4 weeks each. The investigators will additionally ask that participants avoid eating grapes and certain other antioxidant/grape-related foods and beverages throughout the 13-week study. Participants will additionally be asked to complete surveys about their diet, physical activity, and medical history, as well as provide blood samples and body weight measures throughout the course of the study. Participation in the study is expected to last about 6.25 hours over the course of 13 weeks and will include 7 visits.
Recruiting
Paid Trial
Department of Nutritional Sciences
Image of Abcentra Investigational Site in Los Angeles, United States.

Orticumab for Heart Attack

18+
All Sexes
Los Angeles, CA
The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarction who have elevated coronary inflammation based on CCTA. The main question it aims to answer is: Clinical effects of orticumab treatment on inflammation of the coronary artery parameters measured with CCTA Researchers will compare the effects with placebo group after 6 months of treatment Participants will Keep the planned study visit appointments Provide complete information about medical and medical history Speak to the study doctor before changing any of non-study treatments, including starting new medications, receiving any vaccinations, or setting out to join any other clinical studies
Phase 2
Recruiting
Abcentra Investigational Site (+6 Sites)Abcentra
Have you considered Econopred clinical trials? We made a collection of clinical trials featuring Econopred, we think they might fit your search criteria.Go to Trials
Image of Tesla MedBed at Tampa-FL in Tampa, United States.

Biophoton Therapy for Stem Cell Proliferation

18 - 70
All Sexes
Tampa, FL
Study Objective The purpose of this clinical study is to evaluate if biophoton therapy, delivered by Tesla BioHealing® Biophoton Generators (Biophotonizer), can increase self-grown stem cells naturally. Study Design This is a randomized, double-blinded, placebo-controlled intervention clinical study to assess the effectiveness of biophoton therapy in impacting stem cells. Approximately 46 volunteers who want to increase self-grown stem cells will participate in the study. Study Randomization The biostatistician will prepare a randomization schedule including a serial of subject numbers. A subject number will be randomly assigned to each study participant, which will assign them to either the control group or the treatment group. Other than the Informed Consent Form (ICF), all study information will be recorded by using the subject number. The Principal Investigator, study physicians, study nurse, data-entry specialists, and biostatisticians, as well as the participants, will be blinded about who received which product during the first two weeks of study participation.
Recruiting
Online Trial
Tesla MedBed at Tampa-FL (+1 Sites)James Z Liu, MD, PhD
Image of Goldring Center for High Performance Sport in Toronto, Canada.

Physical Activity for Delayed Onset Muscle Soreness

18 - 35
All Sexes
Toronto, Canada
After completing novel activity or exercise we may experience exercise-induced muscle damage (EIMD), resulting in a period of reduced muscle function and delayed onset muscle soreness (DOMS). DOMS is characterized by muscle pain and tenderness that typically resolves within a week. While the precise cause of DOMS is unknown, there is growing evidence implicating damage to the connective tissue that surrounds our muscle fibers and is related to a small amount of inflammation. This inflammation is a normal part of our body's ability to recovery from injuries and may be visualized through the use of ultrasound technology. A variety of recovery techniques have been proposed that may help with the recovery of DOMS such as massage and electrical muscle stimulation, but these are not always accessible. Therefore, we are interested in investigating whether the number of daily steps can affect how you experience DOMS.
Waitlist Available
Has No Placebo
Goldring Center for High Performance Sport
Image of UCSF in San Francisco, United States.

Moisturizers for Aging

65+
All Sexes
San Francisco, CA
This is a randomized, investigator-blinded, self-controlled pilot study of the physiologic response to topical moisturizers among older adults with dry skin. The overarching hypothesis is that skin barrier decline is an important source of chronic inflammation, and that skin barrier restoration with moisturizers can reduce serum biomarkers of inflammation. The primary objective is to determine the feasibility for a larger trial, and the secondary objectives are to determine the extent to which measures of serum inflammation, skin barrier function, and the skin microbiome change in response to moisturizers. Participants will be asked to apply one of two topical moisturizers that are widely available over the counter in the US (Vaseline® 100% pure petroleum jelly or CeraVe® moisturizing cream) once daily for 4 weeks to the front of the torso, buttocks, arms, and legs. Subjects will act as their own control (i.e. they will be asked to apply the study moisturizer they are randomized to for one intervention period (4 weeks) and not to apply topical moisturizers for the other 4- week intervention period). Participants will be randomized in a 1:1:1:1 ratio to one of 4 treatment groups: i. no intervention then CeraVe; ii. CeraVe then no intervention; iii. no intervention then Vaseline; iv. Vaseline then no intervention. At each visit (baseline, week 4, and week 8), participants will undergo skin barrier testing, skin microbiome sampling, and phlebotomy to measure serum inflammatory markers.
Phase 4
Recruiting
UCSFKatrina Abuabara, MD
Have you considered Econopred clinical trials? We made a collection of clinical trials featuring Econopred, we think they might fit your search criteria.Go to Trials
Image of University of California, San Diego Altman Clinical and Translational Research Institute in San Diego, United States.

Mediterranean Diet for Inflammation Post-Colonoscopy

18+
All Sexes
San Diego, CA
This study aims to investigate the impact of various healthy diets, specifically a modified plant-based Mediterranean diet, on the gut microbiome and overall well-being post-colonoscopy. The investigators hypothesize that certain diets can positively influence gut bacteria, reducing inflammation and enhancing metabolic signals. To explore this, they will utilize metagenomic testing on stool samples to analyze the DNA of gut microorganisms. Additionally, they will conduct immune profiling on serum samples and perform metabolomic analysis to comprehensively evaluate the diet-induced changes in immune response and metabolic pathways. This multi-faceted approach will help them understand how dietary changes affect the composition and function of the gut microbiome, immune function, and overall metabolism.
Recruiting
Has No Placebo
University of California, San Diego Altman Clinical and Translational Research Institute
Have you considered Econopred clinical trials? We made a collection of clinical trials featuring Econopred, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security